Advances in drugs and surgical treatment of fungal endophthalmitis
10.3980/j.issn.1672-5123.2019.12.15
- VernacularTitle:真菌性眼内炎的药物和手术治疗进展
- Author:
Xing Chen
1
Author Information
1. 1Department of Ophthalmology, Wuxi 9th People's Hospital, Wuxi 214062, Jiangsu Province, China; 2Department of Fundus Diseases and Ocular Trauma, LiXiang Eye Hospital of Soochow University, Suzhou215021, Jiangsu Province, China
- Publication Type:Journal Article
- Keywords:
fungal;
endophthalmitis;
treatment;
drug;
vitrectomy
- From:
International Eye Science
2019;19(12):2064-2067
- CountryChina
- Language:Chinese
-
Abstract:
The prognosis of fungal endophthalmitis is usually poor. Currently, it is confusing in the drugs and surgical treatment and has been explored and progressed. Traditional drugs include amphotericin B, fluconazole and flucytosine. A new generation of drugs includes liposomal amphotericin B, Voriconazole, and caspofungin. Vitrectomy combined with systemic, topical and intraocular application of drugs is particularly important for the treatment of fungal endophthalmitis. This article reviews the current and ongoing development of drugs and surgical treatment of fungal endophthalmitis.
- Full text:201912015.pdf
